All In Biotech

Free tool

FAERS Monitor: Drizalma Sprinkle

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 212516 or its brand name (Drizalma Sprinkle, Duloxetine Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

52,942

Serious

38,285

72% of reports

Hospitalization

17,428

Death reported

5,746

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective4,198
  • fatigue3,892
  • nausea3,793
  • off label use3,210
  • pain2,934
  • headache2,804
  • diarrhoea2,737
  • dizziness2,319
  • fall2,246
  • vomiting2,032
  • toxicity to various agents1,892
  • arthralgia1,876
  • completed suicide1,814
  • dyspnoea1,759
  • drug interaction1,752

Reports by year received

View as table
YearReports
200523
200642
200772
2008145
200992
2010129
2011149
2012124
2013382
20141,019
20151,785
20162,557
20173,266
20184,324
20195,068
20205,408
20214,825
20224,822
20234,722
20244,707
20255,172
20264,109

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,001,217 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
completed suicideSignal1,8148.88.412,342
toxicity to various agentsSignal1,8924.54.35,124
drug interactionSignal1,7524.44.24,625
fallSignal2,2462.72.62,410
fatigue3,8922.01.91,982
nausea3,7931.91.91,695
pain2,9341.91.81,285
dizziness2,3191.91.8924
arthralgia1,8761.81.7671
headache2,8041.81.7983
vomiting2,0321.71.6623
diarrhoea2,7371.71.6787
off label use3,2101.51.4480
drug ineffective4,1981.31.2250
dyspnoea1,7591.21.280

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.